News Center
With the tenet of "Healthy China, Dedicated commitment", Linuo Pharmaceuticals increases cooperation and association with external scientific research institutes while innovating and developing independently.
04
2023
-
12
Hand in hand to create another great cause | Linuo Pharmaceuticals signed a contract with Haikou Tianxingjian!
Classification：
News
Corporate News
Recently, Shandong Linuo Pharmaceutical Co., Ltd. (hereinafter referred to as "Linuo Pharmaceutical") and Haikou Tianxingjian Pharmaceutical Research Co., Ltd. (hereinafter referred to as "Tianxingjian") signed a cooperation agreement at Haikou Tianxingjian headquarters.
the two sides will follow the principle of "mutual benefit and common development,We will continue to deepen cooperative relations, expand areas of cooperation and enhance the value of cooperation.
lino pharmaceutical is the domestic API subdivision track leading enterprisesKeyuan Pharmaceutical（Stock Code 301281.SZ), is committed to using digital medicine to protect life and health, through the "patient education science, disease tracking, health reminders, pharmacological analysis, rehabilitation tutorial" and other modules.Full lifecycle health management for patients with chronic diseaseTo bring patients a more accurate, scientific and efficient medical service experience.
Tianxingjian is a state-level high-tech enterprise mainly engaged in drug research and experimental development,Has a high-quality research team and advanced R & D equipmentWith its integrity, strength and product quality, it has been awarded the qualifications and honors of "innovative small and medium-sized enterprises" and "national high-tech enterprises.
This cooperation will help both sides in the new stage of developmentImprove R & D capabilities, optimize product structure, and enhance market competitiveness,Better health solutions for patients.The two sides work together to open a new chapter in the development of the pharmaceutical field.
Related news
2026-05-18
On May 16–17, Wu Xiaobo, known as “China’s foremost financial writer” and a renowned entrepreneur, led a delegation to visit and inspect Keyuan Pharmaceutical (stock code: 301281.SZ). The group focused on the company’s achievements in integrating smart manufacturing with digital AI technologies in the pharmaceutical sector, engaged in in-depth discussions with its core management team, and expressed high praise for the company’s practical approach to driving industrial upgrading through digital and intelligent transformation. Gao Yuankun, Chairman and President of Linuo Group, along with Li Hongfu, Chairman of Keyuan Pharmaceutical, and Wei Zhiguo, President of the company, accompanied the delegation during the visit.
ADD：#30766 Jingshidong Road, Linuo High-tech Park, Jinan, Shandong Province, P. R. China